Melt Pharmaceuticals
Industry
- Pharmaceuticals
- Drug Delivery
- Biotechnology
See more in Biomedtracker
Latest on Melt Pharmaceuticals
Scrip
• By Mandy Jackson
April began with a flurry of new venture capital mega-rounds of $100m or more – a $160.5m series C round for Obsidian Therapeutics, Inc. , a $132m series B for Alterome Therapeutics, Inc. and a $12
Scrip
• By Joseph Haas
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bayer, Twist Collaboration Gives German
Scrip
• By Mandy Jackson
The number of initial public offerings in the US by biopharmaceutical companies in 2023 may be able to at least match the number of IPOs in 2022 now that another company has made its stock market debu